MentionFox
Home › funding signals › Luminist Labs
Accelerator · announced

Luminist Labs (YC W16) — Diagnostic platform for early detection of liver disease

Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.

Luminist Labs is a Y Combinator company in the Winter 2016 batch. Its directory entry describes it as: Diagnostic platform for early detection of liver disease. The founder listed is Storm Stillman (Founder/CEO) (Y Combinator directory entry, November 12, 2015).

6 more companies from YC Winter 2016 ↓

Run the free check on Luminist Labs →

Sell to companies like Luminist Labs? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Luminist Labs

New accelerator entry · 2015-11-12 · the record

Winter 2016
batch
2
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2016
Announced2015-11-12
StageEarly
StatusAcquired
Team size2
IndustryHealthcare
Sub-industryHealthcare -> Diagnostics
SectorsMedical Devices, Diagnostics, Genomics
RegionsUnited States of America, America / Canada
BasedNew York City, NY, USA
HiringNo
Sitehttp://luministlabs.com
Founded2015
Previously known asLuminist

Pitching, partnering or investing alongside them? See who really runs and owns Luminist Labs.

Free to see. No signup.

Keep reading

More on Luminist Labs and the records around it.

Also in YC Winter 2016

Same batch, Healthcare first.

What do you want to do with Luminist Labs?

Get the full cited report on Luminist Labs

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Luminist Labs: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.

Want the whole picture on Luminist Labs?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Luminist Labs: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Luminist Labs covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Luminist Labs: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Luminist Labs. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups Medical device and diagnostics startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Luminist Labs: Accepted into Y Combinator Winter 2016
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-luminist-labs
Last updated 2026-10-29
Primary record: Y Combinator directory entry
Luminist Labs (YC W16) — Diagnostic platform for early detection of liver disease. MentionFox, 2026-10-29. https://mentionfox.com/funding/yc-luminist-labs